Etiological Diagnosis of Traveler's Diarrhoea (DIAVOY)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02866201|
Recruitment Status : Unknown
Verified August 2016 by Assistance Publique Hopitaux De Marseille.
Recruitment status was: Recruiting
First Posted : August 15, 2016
Last Update Posted : August 15, 2016
Traveler's diarrhoea or turista is the most common disease in travelers. It has been reported based on studies in 20 to 60% of travelers, depending among other conditions and travel destinations. Currently, less than 30% of the etiology of diarrhoea is identified by bacteriological v,irological and parasitology traditional techniques. This ignorance of the diarrhoea etiology causes difficulties in the establishment of a specific and rapid management in this extremely common condition and having a significant cost to society. Technological advances in laboratory diagnosis, such as quantitative real-time Polymerase Chain Reaction (PCR), can allow us now to improve the etiological diagnosis of traveler's diarrhoea using simple rectal swabs.
So, the principal objective of this study is to assess the efficacy of a new diagnosis strategy in order to establissh the etiological diagnosis of traveler's diarrhoea. The hypothesis consists in improving the number of patients with a confirmed etiological diagnosis of traveler's diarrhoea by 5%.
|Condition or disease||Intervention/treatment||Phase|
|Traveler's Diarrhoea||Other: Rectal swab||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||7500 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Study Start Date :||August 2013|
|Estimated Primary Completion Date :||February 2019|
|Estimated Study Completion Date :||August 2019|
Experimental: Patient suffering from traveler's diarrhoea
Patient suffering form traveler's diarrhoea during a stay (up to 3 months) outside metropolitan France
Other: Rectal swab
- Percentage of patients with a confirmed etiological diagnosis of traveler's diarrhoea [ Time Frame: Up to 6 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02866201
|Contact: Philippe GAUTRET||04 91 96 89 35 ext +firstname.lastname@example.org|
|Contact: Alexandra GIULIANI||04 91 38 28 70 ext +email@example.com|
|Assistance Publique Hopitaux de Marseille||Recruiting|
|Marseille, France, 13354|
|Contact: philippe BROUQUI|
|Study Director:||Catherine GEINDRE||Assistance Publique Hôpitaux de Marseille|